Human medicines European public assessment report (EPAR): Zypadhera, olanzapine, Date of authorisation: 19/11/2008, Revision: 23, Status: Authorised

Fostering regulatory collaboration to improve access to mpox medicines

Human medicines European public assessment report (EPAR): Tracleer, bosentan, Date of authorisation: 14/05/2002, Revision: 45, Status: Authorised

Highlights from the first Expert Panels and Notified Bodies workshop, Online, European Medicines Agency, Amsterdam, the Netherlands, 22 April 2024

Workshop with Notified Bodies on the Mandatory Scope of the CECP and PECP, Online, European Medicines Agency, Amsterdam, the Netherlands, 22 April 2024

Veterinary medicines European public assessment report (EPAR): BTVPUR, inactivated vaccine against bluetongue virus serotypes 1 and 8, Status: Authorised

Pharmacovigilance Risk Assessment Committee (PRAC): 23 - 26 November 2026, European Medicines Agency, Amsterdam, the Netherlands, from 23 November 2026 to 26 November 2026

Veterinary medicines European public assessment report (EPAR): Nobilis Influenza H5N2, adjuvanted inactivated vaccine against avian influenza virus type A, subtype H5, Status: Authorised

Pharmacovigilance Risk Assessment Committee (PRAC): 26 - 29 October 2026, European Medicines Agency, Amsterdam, the Netherlands, from 26 October 2026 to 29 October 2026

Pharmacovigilance Risk Assessment Committee (PRAC): 28 September - 1 October 2026, European Medicines Agency, Amsterdam, the Netherlands, from 28 September 2026 to 1 October 2026